Dr. Mostafa Omran
My Social Links

Dr. Mostafa Omran

Associate Professor
Chemistry Department, Faculty of Science, Helwan University, Cairo, Egypt

Highest Degree
Ph.D. in Biochemistry from Cairo University, Egypt

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Biochemistry
62%
Biotechnology
90%
Biochemical
75%
Tuberculosis
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
74
Abstracts
0

Selected Publications

  1. Toson, E.S.A., S. Waly and M.M. Omran, 2019. Neutrophil gelatinase-associated lipocalin and oxidative stress markers based-scores to improve the diagnostic accuracy of chronic kidney diseases. J. Biosci. Applied Res., 5: 44-55.
    Direct Link  |  
  2. Omran, M.M., F.M. Zahran, M. Kadry, A.A.M. Belal and M.S. Reihan, 2019. Role of monocyte chemoattractant protein-1 for diagnosing acute myocardial infarction. J. Biosci. Applied Res., 5: 8-17.
    Direct Link  |  
  3. Omran, M.M., F.M. Zahran, M. Kadry, A.A.M. Belal and H. Samir, 2019. The utility of biomarkers in the discrimination of acute coronary syndrome patients. J. Biosci. Applied Res., 5: 60-74.
    Direct Link  |  
  4. Attallah, A.M., M.S. Albannan, M.M. Omran, R. Zayed and S. Saif et al., 2019. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis. Br. J. Biomed. Sci., 76: 105-110.
    CrossRef  |  Direct Link  |  
  5. Omran, M.M., F.M. Zahran, M. Kadry, A.A.M. Belal and T.M. Emran, 2018. Role of myeloperoxidase in early diagnosis of acute myocardial infarction in patients admitted with chest pain. J. Immunoassay Immunochem., 39: 337-347.
    CrossRef  |  Direct Link  |  
  6. Elshemy, M.M., A.E.S. AbdEl-Mejied, F. Zahran, M.M. Omran and A. Nabil, 2018. DPPD ameliorates renal fibrosis induced by HgCl2 in rats. Biosci. Res., 15: 2416-2425.
    Direct Link  |  
  7. Attallah, A.M., M.A.E.H. El-Far, M.M. Omran, A.M. Saeed, M.S. Elbendary, K.A. Attallah and K.F. Mari, 2018. Comparison between glypican-3 and alpha-fetoprotein in discrimination of hepatocellular carcinoma from cirrhotic patients. J. Biosci. Applied Res., 4: 459-468.
    Direct Link  |  
  8. Attallah, A.M., M. El-Far, M.A. Abdelrazek, M.M. Omran and A.Z. Mahmoud et al., 2018. HCV nonstructural protein 4 is associated with aggressiveness features of breast cancer. Breast Cancer, 25: 297-302.
    CrossRef  |  Direct Link  |  
  9. Attallah, A.M., M. El-Far, A.R. Ibrahim, M.A. El-Desouky and M.M. Omran et al., 2018. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1. Br. J. Biomed. Sci., 75: 122-127.
    CrossRef  |  Direct Link  |  
  10. Attallah, A.M., D. Omran, M.M. Omran, M.S. Albannan and R.A. Zayed et al., 2018. Fibro-mark: A panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients. Br. J. Biomed. Sci., 75: 19-23.
    CrossRef  |  Direct Link  |  
  11. Attallah, A.M., D. Omran, M.M. Omran, M.A. Abdelrazek and R. Zayed et al., 2018. Extracellular matrix proteins substantiate IL-28B T allele effect on histological outcome of chronic hepatitis C. Ann. Hepatol., 17: 569-576.
    CrossRef  |  PubMed  |  Direct Link  |  
  12. Farid, K., M.M. Omran, R.E. Farag, M.M. Arafa and T.M. Emran, 2017. Development and evaluation of a novel score for prediction of large oesophageal varices in patients with hepatitis c virus-induced liver cirrhosis. Br. J. Biomed. Sci., 74: 138-143.
    CrossRef  |  Direct Link  |  
  13. Attallah, A.M., M.M. Omran, A.A. Attallah, M.A. Abdelrazek, K. Farid and I. El-Dosoky, 2017. Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP and BCLC staging systems. Int. J. Clin. Oncol., 22: 332-339.
    CrossRef  |  Direct Link  |  
  14. Attallah, A.M., M. El-Far, M.F. Ghaly, M.M. Omran and M.S. Albannan et al., 2017. Circulating levels of collagen III and MMP-1 in patients with chronic hepatitis C co-infected with hepatitis B virus. Br. J. Biomed. Sci., 74: 95-100.
    CrossRef  |  Direct Link  |  
  15. Attallah, A.M., M. El-Far, M.A. Abdelrazek, M.M. Omran and A.A. Attallah et al., 2017. Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients. Br. J. Biomed. Sci., 74: 170-175.
    CrossRef  |  Direct Link  |  
  16. Abdelrazek, M.A., S.O. Abdallah, A.A. Attallah, M.M. Omran, K. Farid and A.M. Attallah, 2017. Prospective evaluation of HCC-DETECT index in detection of small tumors and early stages of three common Child-Turcotte-Pugh, Okuda and CLIP staging systems. Biosci. Res., 14: 95-103.
    Direct Link  |  
  17. Tabll, A.A., M.A. Kodous, A.T. Abbas, M.M. Omran and E.H. Elsayed, 2016. Association between serum aminotransferase enzymes-lipid profile ratio and spontaneous HCV clearance in blood donors. Future Virol., 11: 19-29.
    CrossRef  |  Direct Link  |  
  18. Omran, M.M., T.M. Emran, K. Farid, F.M. Eltaweel, M.A. Omar and F.B. Bazeed, 2016. An easy and useful noninvasive score based on α-1-acid glycoprotein and C-reactive protein for diagnosis of patients with hepatocellular carcinoma associated with hepatitis C virus infection. J. Immunoassay Immunochem., 37: 273-288.
    CrossRef  |  Direct Link  |  
  19. Attallah, A.M., S.O. Abdallah, M.S. Albannan, M.M. Omran, A.A. Attallah and K. Farid, 2016. Impact of hepatitis C virus/Schistosoma mansoni coinfection on the circulating levels of HCV-NS4 protein and extracellular-matrix deposition in patients with different hepatic fibrosis stages. Am. J. Trop. Med. Hyg., 95: 1044-1050.
    CrossRef  |  Direct Link  |  
  20. Attallah, A.M., M. El-Far, M.M. Omran, M.A. Abdelrazek, A.A. Attallah, A.M. Saeed and K. Farid, 2016. GPC-HCC model: A combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma. Tumor Biol., 37: 12571-12577.
    CrossRef  |  Direct Link  |  
  21. Attallah, A.M., M. El-Far, M.M. Omran, K. Farid and A.A. Attallah et al., 2016. Levels of Schistosoma mansoni circulating antigen in chronic hepatitis C patients with different stages of liver fibrosis. J. Immunoassay Immunochem., 37: 316-330.
    CrossRef  |  Direct Link  |  
  22. Attallah, A.M., S.O. Abdallah, M. El-Far, M.M. Omran and A.A. Tabll et al., 2015. Perinatal transmission of hepatitis C antigens: Envelope 1, envelope 2 and non-structural 4. Infect. Dis., 47: 568-574.
    CrossRef  |  Direct Link  |  
  23. Attallah, A.M., M.A. El-Far, S.O. Abdallah, A.M. El-Waseef and M.M. Omran et al., 2015. Diagnostic performance of Nuclear Matrix Protein (NMP-52) in bladder cancer. Global J. Biotechnol. Biochem., 10: 32-38.
    Direct Link  |  
  24. Attallah, A.M., M. El-Far, S.O. Abdallah, A.M. El-Waseef and M.M. Omran et al., 2015. Combined use of epithelial membrane antigen and nuclear matrix protein 52 as sensitive biomarkers for detection of bladder cancer. Int. J. Biol. Markers, 30: 407-413.
    CrossRef  |  Direct Link  |  
  25. Attallah, A.M., M. El-Far, C.A. Abdel Malak, M.M. Omran and K. Farid et al., 2015. A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma. Ann. Hepatol., 14: 869-880.
    CrossRef  |  Direct Link  |  
  26. Attallah, A.M., M. El-Far, C.A. Abdel Malak, M.M. Omran and K. Farid et al., 2015. Fibro-check: A combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients. Ann. Hepatol., 14: 225-233.
    Direct Link  |  
  27. Attallah, A.M., M. El-Far, C.A. Abdel Malak, M.M. Omran and G.E. Shiha et al., 2015. HCC-DETECT: A combination of nuclear, cytoplasmic, and oncofetal proteins as biomarkers for hepatocellular carcinoma. Tumor Biol., 36: 7667-7674.
    CrossRef  |  Direct Link  |  
  28. Attallah, A.M., S.O. Abdallah, M.A. El-Desouky, M. El-Far and M.M. Omran et al., 2014. A rapid, low-cost quantitative diagnostic method for hepatitis C virus infection using capillary zone electrophoresis. Eur. J. Clin. Microbiol. Infect. Dis., 33: 439-452.
    CrossRef  |  Direct Link  |  
  29. Attallah, A.M., M. El-Far, M.M. Omran, S.O. Abdallah and M.A. El-Desouky et al., 2014. Circulating levels and clinical implications of epithelial membrane antigen and cytokeratin-1 in women with breast cancer: Can their ratio improve the results? Tumor Biol., 35: 10737-10745.
    CrossRef  |  Direct Link  |  
  30. Abdel-Raouf, M., A.M. Attallah, M.M. Omran, M.S. Albannan, A.A. Attallah and M.I. Abou-Dobara, 2014. The detection of a Helicobacter pylori antigen in some different types of gastrointestinal cancers patients. J. Am. Sci., 10: 19-24.
    Direct Link  |  
  31. Attallah, A.M., S.O. Abdallah, A.A. Attallah, M.M. Omran and K. Farid et al., 2013. Diagnostic value of fibronectin discriminant score for predicting liver fibrosis stages in chronic hepatitis C virus patients. Ann. Hepatol., 12: 44-53.
    Direct Link  |  
  32. Attallah, A.M., M.M. Omran, A.A. Attallah, S.O. Abdallah and K. Farid et al., 2013. HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: A large-scale, multicentre study. Br. J. Cancer, 109: 1657-1665.
    CrossRef  |  Direct Link  |  
  33. Attallah, A.M., M. El-Far, M.M. Omran, K. Farid, M.S. Albannan and I. El-Dosoky, 2013. Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients. J. Clin. Lab. Anal., 27: 121-129.
    CrossRef  |  Direct Link  |  
  34. Attallah, A.M., M.M. Omran, W.A. Nasif, M.F. Ghaly and A.E.R.R. El-Shanshoury et al., 2012. Diagnostic performances of hepatitis C virus-NS4 antigen in patients with different liver pathologies. Arch. Med. Res., 43: 555-562.
    CrossRef  |  PubMed  |  Direct Link  |  
  35. Attallah, A.M., M.M. Omran, K. Farid, M. El-Bendary, T.M. Emran, M.S. Albannan and I. El-Dosoky, 2012. Development of a novel score for liver fibrosis staging and comparison with eight simple laboratory scores in large numbers of HCV-monoinfected patients. Clin. Chim. Acta, 413: 1725-1730.
    CrossRef  |  Direct Link  |  
  36. Omran, M.M., K. Farid, T.M. Emran and A.A. Attallah, 2011. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients. Arab J. Gastroenterol., 12: 74-79.
    CrossRef  |  Direct Link  |  
  37. Attallah, A.M., S.O. Abdallah, A.S. El Sayed, M.M. Omran, M. El-Bendary, K. Farid and M. Kadry, 2011. Non-invasive predictive score of fibrosis stages in chronic hepatitis C patients based on epithelial membrane antigen in the blood in combination with routine laboratory markers. Hepatol. Res., 41: 1075-1084.
    CrossRef  |  Direct Link  |  
  38. Attallah, A.M., N.K. Badr El-Din, M.M. Omran, K. Farid, A.H. El-Wahab, M. El-Bendary and I. El-Dosoky, 2011. Assessment of matrix metalloproteinase-1 for marking liver cirrhosis in chronic hepatitis C patients. Egypt. J. Immunol., 18: 33-42.
    PubMed  |  Direct Link  |  
  39. Attallah, A.M., M. El-Far, C.A.A. Malak, F. Zahran and K. Farid et al., 2011. Evaluation of cytokeratin-1 in the diagnosis of hepatocellular carcinoma. Clin. Chim. Acta, 412: 2310-2315.
    CrossRef  |  Direct Link  |  
  40. Attallah, A.M., T.E. Mosa, M.M. Omran, M.M. Abo-Zeid, I. El-Dosoky and Y.M. Shaker, 2007. Immunodetection of collagen types I, II, III and IV for differentiation of liver fibrosis stages in patients with chronic HCV. J. Immunoassay Immunochem., 28: 155-168.
    CrossRef  |  Direct Link  |  
  41. Attallah, A.M., F. Zahran, H. Ismail, M.M. Omran, I. El-Dosoky and G.E. Shiha, 2007. Immunochemical identification and detection of serum fibronectin in liver fibrosis patients with chronic hepatitis C. J. Immunoassay Immunochem., 28: 331-342.
    CrossRef  |  Direct Link  |  
  42. Attallah, A.M., E.A. Toson, G.E. Shiha, M.M. Omran, M.M. Abdel-Aziz and I. El-Dosoky, 2007. Evaluation of serum procollagen aminoterminal propeptide III, laminin and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C. J. Immunoassay Immunochem., 28: 199-211.
    CrossRef  |  Direct Link  |  
  43. Attallah, A.M., G.E. Shiha, M.M. Omran and K.R. Zalata, 2006. A discriminant score based on four routine laboratory blood tests for accurate diagnosis of severe fibrosis and/or liver cirrhosis in Egyptian patients with chronic hepatitis C. Hepatol. Res., 34: 163-169.
    CrossRef  |  Direct Link  |  
  44. Attallah, A.M., E.S.A. Toson, A.M. El-Waseef, M.A. Abo-Seif, M.M. Omran and G.E. Shiha, 2006. Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection. Clin. Chim. Acta, 369: 66-72.
    CrossRef  |  Direct Link  |  
  45. Attallah, A.M., S. Osman, A. Saad, M. Omran, H. Ismail, G. Ibrahim and A. Abo-Naglla, 2005. Application of a circulating antigen detection immunoassay for laboratory diagnosis of extra-pulmonary and pulmonary tuberculosis. Clin. Chim. Acta, 356: 58-66.
    CrossRef  |  Direct Link  |  
  46. Attallah, A.M., C.A. Abdel Malak, H. Ismail, A.H. El-Saggan, M.M. Omran and A.A. Tabll, 2003. Rapid and simple detection of a Mycobacterium tuberculosis circulating antigen in serum using dot-ELISA for field diagnosis of pulmonary tuberculosis. J. Immunoassay Immunochem., 24: 73-87.
    CrossRef  |  Direct Link  |  
  47. Attallah, A.M., H.M. Sharada, M.S. Abdalla and M.M. Omran, 2000. Purification and biochemical characterization of a 55 kDa Mycobacterium tuberculosis antigen. Egypt. J. Biochem., 18: 27-38.